DICE Therapeutics Inc (DICE)


Stock Price Forecast

Aug. 9, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading DICE Therapeutics Inc chart...

About the Company

We do not have any company description for DICE Therapeutics Inc at the moment.

Exchange

NASDAQ

$1M

Total Revenue

71

Employees

$588M

Market Capitalization

-9.92

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $DICE News

Health Care Company Eli Lilly Announces Acquisition of DICE Therapeutics

9mon ago, source: Hosted on MSN

DICE Therapeutics Inc is a biopharmaceutical company leveraging proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and ...

DICE Therapeutics To Participate At Upcoming Investor Conferences

1y ago, source: Mena FN

About DICE Therapeutics, Inc. DICE Therapeutics, Inc. is a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to ...

DMAC DiaMedica Therapeutics Inc.

16h ago, source: Seeking Alpha

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. The company ...

12 Best Biotech Penny Stocks to Invest In

3d ago, source: Yahoo Finance

One indication of this optimism is the performance of biotech giants like GlaxoSmithKline plc (NYSE:GSK), Eli Lilly and Company (NYSE:LLY), and AbbVie Inc ... of DICE Therapeutics, POINT Biopharma ...

Michael P. Rubin's Net Worth

7d ago, source: Benzinga.com

This is based on reported shares across multiple companies, which include Vigil Neuroscience, Inc., DICE Therapeutics, Inc., IsoPlexis Corp, and Telesis Bio Inc.. Attention insiders: Dive deeper ...

Omega Therapeutics Inc OMGA

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Kintara Therapeutics Inc KTRA

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Seres Therapeutics Inc (MCRB) Reports Encouraging Sales Growth and Strategic Cost Savings in 2023

23d ago, source: Yahoo Finance

Warning! GuruFocus has detected 8 Warning Signs with MCRB. On March 5, 2024, Seres Therapeutics Inc (NASDAQ:MCRB) released its 8-K filing, announcing the fourth quarter and full year financial ...

OTLK Outlook Therapeutics, Inc.

1d ago, source: Seeking Alpha

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead ...

Akero Therapeutics Inc (AKRO)

13d ago, source: Investing

Jonathan Young, the Chief Operating Officer of Akero Therapeutics, Inc. (NASDAQ:AKRO), has recently sold shares of the company's common stock, generating over $18,000 in the... Akero Therapeutics ...

12 Best Biotech Penny Stocks to Invest In

3d ago, source: InvestingChannel on MSN

In this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip our detailed analysis of these ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...